富含和胺的血清分离因子是非小细胞肺癌和其他固体癌症的诊断标记物
Libang Yang1, Adam Gilbertsen1, Blake Jacobson2
1Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
International journal of molecular sciences
|August 29, 2024
概括
血清SFPQ水平可以帮助诊断非小细胞肺癌 (NSCLC) 和其他固体瘤. 这种新型生物标志物在区分癌症患者和健康个体方面表现出高灵敏度和特异性.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 癌症标志物对于诊断,预后和治疗监测至关重要.
- 富含普罗林和谷氨酸的分离因子 (SFPQ) 与癌症生长和转移有关.
- 在非小细胞肺癌 (NSCLC) 和其他固体瘤中观察到高SFPQ表达.
研究的目的:
- 开发和验证一种用于检测SFPQ的新型酶相关免疫吸收试验 (ELISA).
- 评估血清SFPQ作为NSCLC和其他固体癌症的潜在诊断生物标志物.
主要方法:
- 开发一种基于ELISA的特定双单克隆抗体 (mAb) 用于SFPQ检测.
- 在患有NSCLC,其他固体癌症和健康对照患者中量化血清SFPQ水平.
- 统计分析包括ROC曲线分析,以评估诊断性能.
主要成果:
- 开发的ELISA专门检测到人类血清中的SFPQ.
- 与对照组相比,NSCLC和其他固体癌症患者的血清SFPQ水平显著升高.
- 对于NSCLC检测,血清SFPQ的AUC达到0.876,敏感度为87%,特异性为94%.
结论:
- 血清SFPQ是一种有前途的新生物标志物,用于诊断NSCLC.
- 血清SFPQ可以作为各种固体恶性瘤的宝贵诊断工具.
- 开发的ELISA提供了一种可靠的方法,用于SFPQ在临床环境中的量化.
相关概念视频
RNA Splicing
56.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.2K
Alternative RNA Splicing
21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K


